ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 42 • 2013 ACR/ARHP Annual Meeting

    Inhibition Of B Cell Differentiation To The Plasmablast and Plasma Cell Lineage By CC-220, a Potent Modulator Of The Cereblon E3 Ubiquitin Ligase Complex

    Peter Schafer1, Lori Capone2, Lei Wu1 and Rajesh Chopra3, 1Department of Translational Development, Celgene Corporation, Summit, NJ, 2Celgene Corporation, Summit, NJ, 3Translational Development, Celgene Corporation, Summit, NJ

    Background/Purpose: CC-220 is an immunomodulatory compound which binds to the CUL4 family E3 ubiquitin ligase complex protein cereblon (CRBN) with high affinity and modulates the…
  • Abstract Number: 43 • 2013 ACR/ARHP Annual Meeting

    Overexpression Of Lamin A In Mesenchymal STEM CELLS Compromises Chondrogenesis and Enhances Adipogenesis

    Jesús Mateos1,2, Arancha Landeira1,2, Alexandre De la Fuente1,2, Iván Lesende-Rodríguez1,3, Pablo Fernández-Pernas1,3, Maria Carmen Arufe2,3 and Francisco J. Blanco1,2,4, 1Rhematology Division, ProteoRed/ISCIII. INIBIC-Hospital A Coruña, 15006, A Coruña, Spain, 2CIBER-BBN, Zaragoza, Spain, 3Department of Medicine, Area of Anatomy and Human Embryology, University of A Coruña-INIBIC, A Coruña, Spain, 4Department of Medicine. University of Santiago de Compostela, Santiago de Compostela, Spain

    Background/Purpose: Previous work by our group and others indicated that an accumulation of lamin A (LMNA) is associated with the osteoarthritis (OA) chondrocyte phenotype. Mutations…
  • Abstract Number: 44 • 2013 ACR/ARHP Annual Meeting

    Suppressor Of Cytokine Signaling 3 Negatively Modulates Leptin-Mediated Catabolic and Proinflammatory Effects In Cartilage – New Potential Mechanism To Target Obesity-Induced Osteoarthritis

    Anna Koskinen1, Katriina Vuolteenaho1, Riku Korhonen1, Teemu Moilanen1,2 and Eeva Moilanen1, 1The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital, Tampere, Finland, 2Coxa Hospital for Joint Replacement, Tampere, Finland

    Background/Purpose: Adipocytokine leptin has been suggested to link obesity and osteoarthritis (OA). Initially leptin was found to regulate energy metabolism through central nervous system. More…
  • Abstract Number: 46 • 2013 ACR/ARHP Annual Meeting

    Alarmins S100A8/A9 Regulate Osteophyte Formation In Experimental Osteoarthritis With High Synovial Activation

    Rik Schelbergen1, Arjen B. Blom1, Wouter de Munter1, Annet W. Sloetjes2, Thomas Vogl3, Johannes Roth4, Wim B. van den Berg5 and Peter L.E.M. van Lent1, 1Rheumatology Research & Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Experimental Rheumatology (272), Radboud university medical center, Nijmegen, Netherlands, 3Institute of Immunology, University of Muenster, Muenster, Germany, 4Immunology, Institute of Immunology University of Muenster, Muenster, Germany, 5Rheumatology Research and Advanced Therapeutics, Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

    Background/Purpose: Osteophytes are cartilage capped, bony outgrowths that limit joint movement and originate from the periosteum or from ligaments during osteoarthritis (OA). There is increasing…
  • Abstract Number: 47 • 2013 ACR/ARHP Annual Meeting

    Exogenous Hydrogen Sulfide Donors Show Anti-Catabolic and Anti-Inflammatory Properties But Limited Anti-Oxidant Capability On Human Articular Osteoarthritic Chondrocytes

    Elena F. Burguera1,2, Angela Vela-Anero2,3, Rosa Meijide-Failde2 and Francisco J. Blanco1,4, 1Rheumatology Service, INIBIC-Hospital Universitario A Coruña, A Coruña, Spain, 2Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC). Sergas. Universidade da Coruña (UDC)., Grupo de Bioingeniería Tisular y Terapia Celular (CBTTC-CHUAC). CIBER-BBN/ISCIII., A Coruña, Spain, 3Department of Medicine, University of A Coruña, A Coruña, Spain, 4Tissue Engineering and Cellular Therapy Group (CBTTC-CHUAC), CIBER BBN/ISCIII, A Coruña, Spain

    Background/Purpose: Osteoarthritis (OA) is characterized by an imbalance between catabolism and anabolism, higher than normal levels of matrix metalloproteinases (MMPs), an increase in inflammatory markers…
  • Abstract Number: 48 • 2013 ACR/ARHP Annual Meeting

    The In Vivo Role Of Bone Specific EphB4 Receptor Overexpression In Osteoarthritic Synovial Membrane

    Gladys Valverde-Franco1, David Hum1, Bertrand Lussier2, Koichi Matsuo3, Jean-Pierre Pelletier1, Mohit Kapoor1 and Johanne Martel-Pelletier1, 1Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, 2Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Montreal, Saint-Hyacinthe, QC, Canada, 3Laboratory of Cell and Tissue Biology, School of Medicine, Keio University, Tokyo, Japan

    Background/Purpose: Osteoarthritis (OA) is characterized by progressive destruction of all joint tissues including inflammation of the synovial membrane. The histological changes that occur in OA…
  • Abstract Number: 49 • 2013 ACR/ARHP Annual Meeting

    Chondrocyte-Specific Bone Morphogenetic Protein-2 Overexpression Results In Severe Aggravation Of Osteophyte Formation In Experimental Osteoarthritis Without Altering Cartilage Damage In Young Mice

    Esmeralda N. Blaney Davidson1, Elly L. Vitters2, Miranda B. Bennink3, Fons AJ Loo2, Wim B. van den Berg3 and Peter M. van der Kraan2, 1Rheumatology Research & Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology Research and Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 3Rheumatology Research and Advanced Therapeutics, Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

    Background/Purpose: In murine osteoarthritis (OA) models chondrocytes surrounding lesions express elevated levels of Bone Morphogenetic Protein-2 (BMP2). This growth factor is well known for its…
  • Abstract Number: 50 • 2013 ACR/ARHP Annual Meeting

    Cartilage Matrix Remodeling and Activation Of Canonical Wnt- Signaling Precedes Calcification and OA-Like Changes In Mice

    Jessica Bertrand1, Tabea Kräft2, Yvonne Nitschke3, Thelonius Hawellek4, Jan Hubert4, Lars Godmann5 and Thomas Pap5, 1Institute of Experimental Musculoskeletal Medicine (IEMM), University Hospital Münster, Münster, Germany, 2Inst, University Hospital Münster, Muenster, Germany, 3University Hospital Münster, Muenster, Germany, 4University Hospital Hamburg, Hamburg, Germany, 5Institute of Experimental Muskuloskeletal Medicine, University Hospital Münster, Münster, Germany

    Background/Purpose: Calcification of cartilage is a common finding during osteoarthritis (OA) and is directly linked to the severity of cartilage degradation. We have found in…
  • Abstract Number: 51 • 2013 ACR/ARHP Annual Meeting

    Collagen-Based Microspheres Delivering TGF-β3 For Mesenchymal STEM CELL Differentiation: An Innovative Strategy For Cartilage Engineering

    Marc Mathieu1, E Belamie2, M-N Labour2, Sylvain Vigier2, Christian Jorgensen3 and Daniele Noel4, 1INSERM U844, Montpellier, France, 2ICGM UMR 5253, MONTPELLIER, France, 3Department of therapy & Immuno-Rhumatology, Inserm U844, CHU saint-Eloi, Université Montpellier 1, CHU Lapeyronie, Montpellier, France, 4Inserm U844, UM1, Montpellier, France

    Background/Purpose: Because of a poor self-healing ability, joint cartilage undergoes progressive degradation in the course of aging or following traumatic injuries. One promising therapeutic approach…
  • Abstract Number: 52 • 2013 ACR/ARHP Annual Meeting

    Altered Lipid Metabolism In Osteoarthritis With Subsequent Proinflammatory Properties Of Apolipoprotein A-I

    Dominique de Seny1, Gaël Cobraiville2, Edith Charlier3, Sophie Neuville2, Laurence Lutteri4, Denis Malaise5, Olivier Malaise3, Jean-Paul Chapelle4, Biserka Relic1 and Michel G. Malaise1, 1Department of Rheumatology, GIGA Research - University of Liège - CHU of Liège, Liège, Belgium, 2GIGA Research - University of Liège - CHU of Liège, Liège, Belgium, 3Department of Rheumatology, GIGA Research - University of Liège - CHU Liège, Liège, Belgium, 4Medical Chemistry - CHU Liège, Liège, Belgium, 5University of Liège, Liège, Belgium

    Background/Purpose: Osteoarthritis (OA) is associated with a local inflammatory process. It is now considered as a metabolic syndrome rather than due to aging or mechanical…
  • Abstract Number: 54 • 2013 ACR/ARHP Annual Meeting

    ANTI-Fibrotic and ANTI-Hypertrophic Effect Of Adipose Mesenchymal Stromal CELLS On Osteoarthritic Chondrocytes

    Marie Maumus1, C. Manferdini2, Karine Toupet1, A. Piacentini2, A. Gabusi2, A. Facchini2, G. Lisignoli2, Christian Jorgensen3 and Daniele Noel4, 1Université Montpellier1, INSERM U844, Montpellier, France, 2Laboratorio di Immunoreumatologia e Rigenerazione tissutale, IOR BOLOGNA, BOLOGNA, Italy, 3Department of therapy & Immuno-Rhumatology, Inserm U844, CHU saint-Eloi, Université Montpellier 1, CHU Lapeyronie, Montpellier, France, 4Inserm U844, UM1, Montpellier, France

    Background/Purpose: Mesenchymal stem cells (MSC) isolated from bone marrow (MSC) or adipose (ASC) tissues secrete a large amount of trophic factors. The possibility that these…
  • Abstract Number: 55 • 2013 ACR/ARHP Annual Meeting

    Glucocorticoid Receptor Modulator Compound A Does Not Induce Leptin In Human Osteoarthritic Synovial Fibroblasts and In Dedifferentiated Chondrocytes

    Olivier Malaise1, Biserka Relic2, Edith Charlier1, Mustapha Zeddou1, Florence Quesada-Calvo3, Sophie Neuville4, Dominique de Seny2 and Michel G. Malaise2, 1Department of Rheumatology, GIGA Research - University of Liège - CHU Liège, Liège, Belgium, 2Department of Rheumatology, GIGA Research - University of Liège - CHU of Liège, Liège, Belgium, 3Gastroenterology, GIGA Research - University of Liège - CHU Liège, Liège, Belgium, 4GIGA Research - University of Liège - CHU of Liège, Liège, Belgium

    Background/Purpose: Leptin is generally considered detrimental in osteoarthritis (OA)  as it can induce IL-8 in synovial fibroblasts (SF) and matrix metalloproteinases in chondrocytes. We recently…
  • Abstract Number: 56 • 2013 ACR/ARHP Annual Meeting

    Age-Related Loss Of The Transforming Growth Factor Beta Receptor ALK5 Precedes Osteoarthritis Development In Cartilage

    Arjan van Caam1, Esmeralda N. Blaney Davidson2, Eva Thijssen1, Wim B. van den Berg1 and Peter M. van der Kraan1, 1Rheumatology Research and Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology Research & Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

    Background/Purpose: Osteoarthritis (OA) is the most common joint disease and (old) age is its main risk factor.  One of OA's main hallmarks is degradation of…
  • Abstract Number: 57 • 2013 ACR/ARHP Annual Meeting

    Role Of Procatabolic Cytokines In Dysregulation Of O-Linked N-Acetylglucosamine Modified Proteins In Human Osteoarthritic Chondrocytes

    Raquel Largo1, Ane Larranaga-Vera2, Sandra Pérez-Baos2, Gabriel Herrero-Beaumont2 and Jessica Andrés-Bergós2,3, 1Bone and Joint Research Unit, IIS, Jiménez Díaz Foundation University Hospital, Madrid, Spain, 2Joint and Bone Research Unit. IIS-Fundación Jiménez Díaz. UAM, Madrid, Spain, 3Tissue Engineering Repair and Regeneration Program, Hospital for Special Surgery and Weill Cornell Medical College, New York, NY

    Background/Purpose: Nuclear and cytoplasmic protein glycosylation by the addition of O-linked N-Acetylglucosamine (O-GlcNAc) to serine and threonine residues is a widespread post-translational modification that has…
  • Abstract Number: 23 • 2013 ACR/ARHP Annual Meeting

    Seizures In Systemic Lupus Erythematosus Are Not An Inflammatory Manifestation Of Lupus Anticoagulant

    Michelle Petri and Hong Fang, Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: About 50% of SLE patients make an antiphospholipid antibody and 10% develop classic antiphospholipid syndrome.  Seizures are one of the components of the SLICC…
  • « Previous Page
  • 1
  • …
  • 2421
  • 2422
  • 2423
  • 2424
  • 2425
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology